Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -45 | -2 | -167 | -26 |
| Net Acquisitions | 0 | 64 | -3,462 | N/A | N/A |
| Other Investing Activity | 0 | 13 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $32 | $-3,464 | $-167 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -237 | 0 |
| Common Stock Issued | N/A | N/A | N/A | 188 | 8,488 |
| Other Financing Activity | 0 | -31 | 0 | -231 | -950 |
| Financing Cash Flow | $N/A | $-31 | $0 | $-280 | $7,538 |
| Exchange Rate Effect | -103 | -53 | 242 | 221 | 121 |
| Beginning Cash Position | -2,056 | 15,742 | 20,903 | 22,984 | 16,435 |
| End Cash Position | 11,350 | 13,507 | 15,742 | 20,902 | 22,984 |
| Net Cash Flow | $13,509 | $-2,181 | $-5,403 | $-2,303 | $6,428 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | -45 | -2 | -167 | -26 |
| Free Cash Flow | 0 | -45 | -2 | -167 | -26 |